NAMA News – March 8, 2013March 8, 2013
NAMA Corn Milling Members Hear High Amylase Corn Update
NAMA hosted a conference call on February 22 to brief corn millers on information gleaned from the February 21 meeting of the Syngenta Enogen advisory council. Eleven members heard the update led by Corn Division chairman George Allard, Bunge Milling, Inc. Don Sullins, consultant to the ADM Milling Company also represents NAMA on the council. The group heard Syngenta’s plans for the continued expansion of Enogen high amylase corn. Production in 2013 is expected to nearly triple to 60,000 acres and the number of growers planting the corn will increase from 100 to 252. Syngenta expects eventual Enogen production to hit 2.5 million acres.
NAMA Pays Visit to Key Member of Canada’s Senate
NAMA Vice President Jim Bair met this week in Parliament with Senator JoAnne Buth, Conservative Party member from Manitoba. Bair was in Ottawa for a NAMA-sponsored oat research meeting. Senator Buth, who chairs the Senate Agriculture Committee, met with Jim in the Canadian Embassy in Washington, DC in 2012. On both occasions they discussed issues of mutual importance including US/Canada trade in grain and milled grain products. While in Ottawa, Bair also met with Gordon Harrison, president of the Canadian National Millers Association.
FDA Final Rule on Gluten-Free Labeling Arrives at OMB
FDA’s long-awaited final rule on gluten-free labeling of foods has arrived at the Office of Information and Regulatory Affairs, Office of Management and Budget (OIRA-OMB) for review under Executive Order (EO) 12866. The order requires the agency to analyze the costs and benefits of the rule and, to the extent permitted by law, action only on the basis of a reasoned determination that the benefits justify the costs.
It is somewhat surprising that this final rule is receiving EO12866 review and is noted as economically significant. Most voluntary labeling provisions are not deemed to have significant economic impact. Any conclusions drawn from this fact would be speculation.
OIRA-OMB is allowed 90 days for EO 12866 review, but it may be extended.